Additionally, PCDLBCL,LT frequently exhibits BCL-2 gene rearrangements, gains in chromosome 18, and more commonly exhibits MYC rearrangements when compared to nodal DLBCL [30,89,90]. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.